|
| Issue Date | Title | Author(s) |
| 2024 | Advances in non-Hydroxamate based Histone Deacetylase Inhibitors as Anticancer Agents | Nabih, Nadine W; Jaballah, Maiy Y; Serya, Rabah ; Abouzid, Khaled AM |
| Jun-2024 | Advances in the discovery of activin receptor-like kinase 5 (ALK5) inhibitors | Mansour, Mai A; Hassan, Ghaneya S; Jaballah, Maiy Y; Abouzid, Khaled A M; Serya, Rabah |
| 25-May-2018 | Alkoxyphenylthiazoles with broad-spectrum activity against multidrug-resistant gram-positive bacterial pathogens | ElAwamy, Moustafa; Mohammad, Haroon; Hussien, Abdelrahman; Abutaleb, Nader S; Hagras, Mohamed; Serya, Rabah ; Taher, Azza T; Seleem, Mohamed N; Mayhoub, Abdelrahman S; Khaled A M Abouzid |
| 2023 | AML and FLT3: An update on FDA-approved or under review kinase inhibitors targeting FLT3 kinase | Nada Alaa El-Deen; Mai Jaballah; Abouzid, Khaled ; Dokla, Eman ; Serya, Rabah |
| 2016 | Anti-acetylcholinesterase activity of essential oils and their major constituents from four Ocimum species | Ezzat, Shahira M; Salama, Maha M; Tadros, Mariane G; Serya, Rabah ; Farag, Mohamed A |
| Mar-2013 | Assessment of new anti-HER2 ligands using combined docking, QM/MM scoring and MD simulation | Ahmed, Marawan; Sadek, Maiada M; Serya, Rabah ; Kafafy, Abdel-Hamid N; Wang, Feng; Khaled A M Abouzid |
| 15-Feb-2006 | The benefits of the multi-target approach in drug design and discovery pp 896--897 | Espinoza-Fonseca, L Michel; Ismail, Mohamed AH; Aboul-Enein, Mohamed NY; Abouzid, Khaled AM; Serya, Rabah |
| 30-Jan-2017 | Click and Release: SO2 Prodrugs with Tunable Release Rates | Serya, Rabah ; Khaled A.M.abouzid; Deena S.Lasheen; Xingyue Ji; Binghe Wang; Khaled A M Abouzid |
| 1-Jul-2025 | Design and synthesis of novel Hydroxamate and non-Hydroxamate HDAC inhibitors based on Chromone and Quinazolone scaffolds | Ashraf, Rosaline; Adel, Mai ; Ibrahim, Esraa; Haffez, Hesham; Soror, Sameh; Abouzid, Khaled A M; Serya, Rabah |
| 2016 | Design and Synthesis of quinazoline derivatives: Biological evaluation for their Anticancer and VEGFR inhibitory activities | Metwally, Wegdan M; Hegazy, G; Serya, Rabah ; Eid, S; Abou El Ella, DA |
| 2016 | Design and synthesis of some new tri-substituted pyrazole derivatives as anticancer agents | Fahmy, Hoda H; Srour, Aladdin M; Khater, Mai A; El-Manawaty, May A; Serya, Rabah ; Ismail, Mohamed A |
| 2016 | Design, synthesis and biological evaluation of indazole–pyrimidine based derivatives as anticancer agents with anti-angiogenic and antiproliferative activities | Elsayed, Nevine M. Y.; Abou El Ella, Dalal ; Serya, Rabah A. T. ; Tolba, Mai F.; Shalaby, Raed; Khaled A M Abouzid |
| 2015 | Design, synthesis and biological evaluation of novel quinazoline-based anti-inflammatory agents acting as PDE4B inhibitors | Serya, Rabah ; Abbas, Abeer Hussin; Ismail, Nasser Saad Mohamed; Esmat, Ahmed; Abou El Ella, Dalal ; Abeer Abdelhafiz |
| 2019 | Design, synthesis and molecular docking of novel pyrazolo[1,5-a][1,3,5]triazine derivatives as CDK2 inhibitors | Oudah, Khulood H; Najm, Mazin A A; Samir, Nermin ; Serya, Rabah ; Khaled A M Abouzid |
| Dec-2014 | Design, synthesis, 3D pharmacophore, QSAR, and docking studies of carboxylic acid derivatives as Histone Deacetylase inhibitors and cytotoxic agents | Abdel-Atty, Mona M; Farag, Nahla A; Kassab, Shaymaa E; Serya, Rabah ; Khaled A M Abouzid |
| 2019 | Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activity | Elsayed, Nevine M Y; Serya, Rabah ; Tolba, Mai ; Ahmed, Marawan; Barakat, Khaled; Abou El Ella, Dalal ; Khaled A M Abouzid |
| 2026 | Design, synthesis, in silico, and biological evaluation of novel pyrazolopyrimidinone-based estrogen receptor inhibitors | Hesham, Sara A; Ziko, Laila; Serya, Rabah ; Farag, Nahla A; Mowafy, Samar; Shahin, Mai I; Abouzid, Khaled |
| Nov-2015 | Development of Potent Adenosine Monophosphate Activated Protein Kinase (AMPK) Activators | Fang, Chun-Sheng; Lai, Po-Ting; Kulp, Samuel K; Serya, Rabah ; Ismail, Nasser S M; Chen, Ching-Shih; Dokla, Eman ; Khaled A M Abouzid |
| Sep-2025 | Discovery of Furopyrimidine-Pyrazole Hybrid Compounds Targeting p53-MDM2 Interaction as Anticancer Agents | Mansour, Mai A; Hassan, Ghaneya S; Jaballah, Maiy Y; Dege, Necmi; Şahin, Onur; Sharaky, Marwa; Zhang, Xiaoliang; Su, Ruixin; Kong, Dexin; Abouzid, Khaled A M; Serya, Rabah |
| Apr-2014 | Discovery of new HER2/EGFR dual kinase inhibitors based on the anilinoquinazoline scaffold as potential anti-cancer agents | Sadek, Maiada M; Serya, Rabah ; Kafafy, Abdel-Hamid N; Ahmed, Marawan; Wang, Feng; Khaled A M Abouzid |
